Celldex Therapeutics Competitors and Similar CompaniesClear all
Deciphera Pharmaceuticals's competitors and similar companies include Marker Therapeutics and Celling Biosciences.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. | |
Founding Date | Founding Date 2003 | Founding Date 2018 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Waltham, US HQ Lawrence, US | Locations Houston, US HQ | Locations Austin, US HQ Curitiba, BR Dubai, AE |
Employees | Employees 35037% increase | Employees 888% decrease | Employees 47 |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 36.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($194.9m) (FY, 2023) | Net income ($12.2m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Marker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View companyCelling Biosciences
HQ
Austin, US
Employees
47
Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
View company